Implications for human papillomavirus in penile cancer.

Szczegóły
Abstrakt

Tytuł:: Implications for human papillomavirus in penile cancer.
Autorzy:: Flaherty A; Department of Hematology Oncology, University of South Florida, Tampa, FL.
Kim T; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
Giuliano A; Department of Infectious Disease and Research, Moffitt Cancer Center, Tampa, FL.
Magliocco A; Department of Pathology, Moffitt Cancer Center, Tampa, FL.
Hakky TS; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
Pagliaro LC; Department of Genitourinary Medical Oncology, University of Texas, MD Anderson Cancer Center, Tampa, FL.
Spiess PE; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL. Electronic address: .
Źródło:: Urologic oncology [Urol Oncol] 2014 Jan; Vol. 32 (1), pp. 53.e1-8. Date of Electronic Publication: 2013 Nov 13.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Publication: 2003- : Philadelphia, PA : Elsevier
Original Publication: New York, NY : Elsevier Science,
MeSH Terms:: Alphapapillomavirus/*immunology
Papillomavirus Infections/*immunology
Papillomavirus Vaccines/*immunology
Penile Neoplasms/*immunology
Alphapapillomavirus/physiology ; Host-Pathogen Interactions/drug effects ; Humans ; Male ; Papillomavirus Infections/prevention & control ; Papillomavirus Infections/virology ; Papillomavirus Vaccines/therapeutic use ; Penile Neoplasms/prevention & control ; Penile Neoplasms/virology ; Penis/immunology ; Penis/pathology ; Penis/virology ; Prognosis ; Risk Factors
Contributed Indexing:: Keywords: Human papillomavirus; Penile cancer; Vaccination
Substance Nomenclature:: 0 (Papillomavirus Vaccines)
Entry Date(s):: Date Created: 20131119 Date Completed: 20140926 Latest Revision: 20131223
Update Code:: 20240104
DOI:: 10.1016/j.urolonc.2013.08.010
PMID:: 24239463
: Czasopismo naukowe

Full Text Finder

Human papillomavirus infection (HPV) has been implicated in penile cancer, and although the annual incidence is estimated to be 1,570 in the United States, there are areas of the world in which the incidence is as much as 20-fold higher. Ample data in the literature support testing and vaccination against HPV-related cervical cancer, but for men and penile cancer, these data are lacking. However, some preliminary data would suggest that HPV not only plays an important role in a significant subset of patients with penile cancer but also may be a target for penile cancer prevention as well via initiation of a vaccination program in high-risk male populations.
(Copyright © 2014 Elsevier Inc. All rights reserved.)

Informacja